Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

From Service Provider to Strategic Partner
As drug development grows more complex and timelines compress, sponsors require CDMO relationships built on integration, flexibility, and shared accountability read more
Should Sponsors Provide Source Document Templates?
Sponsor-provided templates provide a compelling opportunity to improve upstream trial execution. However, in today’s world of increasingly complex and data-driven trials, the opportunity comes with important caveats. read more
Extreme Language Ultra-High Potency
The newest generation of small-molecule therapies bring containment needs well beyond those of conventional HPAPIs. What does this mean for the pharma lexicon – and the pharma landscape? read more
Executive Q&A - A Strategic Acquisition: Insights and Ideas
An interview with Brian Morrissey, General Manager of Gaelic Laboratories, which has acquired Athlone Laboratories in a strategic deal that typifies the current pharma M&A landscape and puts all of Ireland’s Beta-Lactam manufacturing capacity under one ownership umbrella. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Ardena Names Chief Scientific Officer
Monday, June 08, 2026
Ardena announced the appointment of Ariane de Ganck, PhD, as Chief Scientific Officer. read more
SGS Expands Bioanalytical Testing Capabilities in North America with Acquisition of CMIC, INC.
Thursday, June 04, 2026
SGS announced that it has acquired CMIC, INC., a specialized provider of bioanalytical testing services based in Chicago, Illinois. read more
Sygnature Discovery, DaltonTx Partner to Expand AI-Enabled Drug Discovery
Thursday, June 04, 2026
Sygnature Discovery announced a strategic collaboration with DaltonTx to strengthen its AI-enabled drug discovery capabilities and accelerate ... read more
Stipple Bio, Lonza Sign Multi-Target ADC Licensing Agreement
Thursday, June 04, 2026
Lonza and Stipple Bio announced a multi-target licensing agreement to support the development of next-generation precision oncology antibody-drug ... read more
Made Scientific Selected as Manufacturer for Columbia University's Autologous and Allogeneic NOVAKnee Program - a First-in-Class Living Biologic Total Knee Replacement
Thursday, June 04, 2026
Made Scientific has been selected as manufacturer for NOVAKnee, a first-in-class living biologic total knee replacement being developed by researchers... read more